Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Development of a prognostic model for breast cancer survival in an open challenge environment.

Cheng WY, Ou Yang TH, Anastassiou D.

Sci Transl Med. 2013 Apr 17;5(181):181ra50. doi: 10.1126/scitranslmed.3005974.

PMID:
23596202
[PubMed - indexed for MEDLINE]
Free Article
2.

Biomolecular events in cancer revealed by attractor metagenes.

Cheng WY, Ou Yang TH, Anastassiou D.

PLoS Comput Biol. 2013;9(2):e1002920. doi: 10.1371/journal.pcbi.1002920. Epub 2013 Feb 21.

PMID:
23468608
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures.

Karn T, Pusztai L, Holtrich U, Iwamoto T, Shiang CY, Schmidt M, Müller V, Solbach C, Gaetje R, Hanker L, Ahr A, Liedtke C, Ruckhäberle E, Kaufmann M, Rody A.

PLoS One. 2011;6(12):e28403. doi: 10.1371/journal.pone.0028403. Epub 2011 Dec 29.

PMID:
22220191
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers.

Bianchini G, Qi Y, Alvarez RH, Iwamoto T, Coutant C, Ibrahim NK, Valero V, Cristofanilli M, Green MC, Radvanyi L, Hatzis C, Hortobagyi GN, Andre F, Gianni L, Symmans WF, Pusztai L.

J Clin Oncol. 2010 Oct 1;28(28):4316-23. doi: 10.1200/JCO.2009.27.2419. Epub 2010 Aug 30. Erratum in: J Clin Oncol. 2010 Nov 10;28(32):4868. J Clin Oncol. 2012 Feb 20;30(6):679.

PMID:
20805453
[PubMed - indexed for MEDLINE]
5.

Combining gene signatures improves prediction of breast cancer survival.

Zhao X, Rødland EA, Sørlie T, Naume B, Langerød A, Frigessi A, Kristensen VN, Børresen-Dale AL, Lingjærde OC.

PLoS One. 2011 Mar 10;6(3):e17845. doi: 10.1371/journal.pone.0017845.

PMID:
21423775
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Systematic analysis of challenge-driven improvements in molecular prognostic models for breast cancer.

Margolin AA, Bilal E, Huang E, Norman TC, Ottestad L, Mecham BH, Sauerwine B, Kellen MR, Mangravite LM, Furia MD, Vollan HK, Rueda OM, Guinney J, Deflaux NA, Hoff B, Schildwachter X, Russnes HG, Park D, Vang VO, Pirtle T, Youseff L, Citro C, Curtis C, Kristensen VN, Hellerstein J, Friend SH, Stolovitzky G, Aparicio S, Caldas C, Børresen-Dale AL.

Sci Transl Med. 2013 Apr 17;5(181):181re1. doi: 10.1126/scitranslmed.3006112.

PMID:
23596205
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.

Rody A, Holtrich U, Pusztai L, Liedtke C, Gaetje R, Ruckhaeberle E, Solbach C, Hanker L, Ahr A, Metzler D, Engels K, Karn T, Kaufmann M.

Breast Cancer Res. 2009;11(2):R15. doi: 10.1186/bcr2234. Epub 2009 Mar 9.

PMID:
19272155
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Mixture classification model based on clinical markers for breast cancer prognosis.

Zeng T, Liu J.

Artif Intell Med. 2010 Feb-Mar;48(2-3):129-37. doi: 10.1016/j.artmed.2009.07.008. Epub 2009 Dec 14.

PMID:
20005686
[PubMed - indexed for MEDLINE]
9.

Prognostic meta-signature of breast cancer developed by two-stage mixture modeling of microarray data.

Shen R, Ghosh D, Chinnaiyan AM.

BMC Genomics. 2004 Dec 14;5(1):94.

PMID:
15598354
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Kinome expression profiling and prognosis of basal breast cancers.

Sabatier R, Finetti P, Mamessier E, Raynaud S, Cervera N, Lambaudie E, Jacquemier J, Viens P, Birnbaum D, Bertucci F.

Mol Cancer. 2011 Jul 21;10:86. doi: 10.1186/1476-4598-10-86.

PMID:
21777462
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

A prognosis classifier for breast cancer based on conserved gene regulation between mammary gland development and tumorigenesis: a multiscale statistical model.

Tian Y, Chen B, Guan P, Kang Y, Lu Z.

PLoS One. 2013;8(4):e60131. doi: 10.1371/journal.pone.0060131. Epub 2013 Apr 2.

PMID:
23565194
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimens.

Sadi AM, Wang DY, Youngson BJ, Miller N, Boerner S, Done SJ, Leong WL.

BMC Cancer. 2011 Jun 16;11:253:1-13. doi: 10.1186/1471-2407-11-25.

PMID:
21679412
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Identification of prognostic molecular features in the reactive stroma of human breast and prostate cancer.

Planche A, Bacac M, Provero P, Fusco C, Delorenzi M, Stehle JC, Stamenkovic I.

PLoS One. 2011;6(5):e18640. doi: 10.1371/journal.pone.0018640. Epub 2011 May 18.

PMID:
21611158
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The humoral immune system has a key prognostic impact in node-negative breast cancer.

Schmidt M, Böhm D, von Törne C, Steiner E, Puhl A, Pilch H, Lehr HA, Hengstler JG, Kölbl H, Gehrmann M.

Cancer Res. 2008 Jul 1;68(13):5405-13. doi: 10.1158/0008-5472.CAN-07-5206.

PMID:
18593943
[PubMed - indexed for MEDLINE]
Free Article
15.

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures.

Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, Haibe-Kains B, Desmedt C, Ignatiadis M, Sengstag T, Schütz F, Goldstein DR, Piccart M, Delorenzi M.

Breast Cancer Res. 2008;10(4):R65. doi: 10.1186/bcr2124. Epub 2008 Jul 28.

PMID:
18662380
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

The rapamycin-regulated gene expression signature determines prognosis for breast cancer.

Akcakanat A, Zhang L, Tsavachidis S, Meric-Bernstam F.

Mol Cancer. 2009 Sep 24;8:75. doi: 10.1186/1476-4598-8-75.

PMID:
19778445
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Identification of prognostic genes for recurrent risk prediction in triple negative breast cancer patients in Taiwan.

Chen LH, Kuo WH, Tsai MH, Chen PC, Hsiao CK, Chuang EY, Chang LY, Hsieh FJ, Lai LC, Chang KJ.

PLoS One. 2011;6(11):e28222. doi: 10.1371/journal.pone.0028222. Epub 2011 Nov 29.

PMID:
22140552
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Bridging cancer biology with the clinic: relative expression of a GRHL2-mediated gene-set pair predicts breast cancer metastasis.

Yang X, Vasudevan P, Parekh V, Penev A, Cunningham JM.

PLoS One. 2013;8(2):e56195. doi: 10.1371/journal.pone.0056195. Epub 2013 Feb 18.

PMID:
23441166
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcome.

Habermann JK, Doering J, Hautaniemi S, Roblick UJ, Bündgen NK, Nicorici D, Kronenwett U, Rathnagiriswaran S, Mettu RK, Ma Y, Krüger S, Bruch HP, Auer G, Guo NL, Ried T.

Int J Cancer. 2009 Apr 1;124(7):1552-64. doi: 10.1002/ijc.24017.

PMID:
19101988
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Protein interaction network underpins concordant prognosis among heterogeneous breast cancer signatures.

Chen J, Sam L, Huang Y, Lee Y, Li J, Liu Y, Xing HR, Lussier YA.

J Biomed Inform. 2010 Jun;43(3):385-96. doi: 10.1016/j.jbi.2010.03.009. Epub 2010 Mar 27.

PMID:
20350617
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk